CRL vs. XLV

In the year-to-date period, CRL achieves a -23.63% return, which is significantly lower than XLV's -2.88% return. Over the past 10 years, CRL has underperformed XLV with an annualized return of 6.90%, while XLV has yielded a comparatively higher 7.66% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CRL Sharpe Ratio is -0.70, which is lower than the XLV Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of CRL and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CRL has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.76%.

The maximum CRL drawdown since its inception was -78.23%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for CRL and XLV. For additional features, visit the drawdowns tool.

Charles River Laboratories International, Inc. (CRL) has a higher volatility of 19.98% compared to Health Care Select Sector SPDR Fund (XLV) at 7.81%. This indicates that CRL's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.